Navigation Links
Phase I/II-data on Systemic Application of the TGF-beta2-inhibitor,AP 12009 to be Presented

REGENSBURG, Germany, May 10th, 2007 - Antisense Pharma today announced, that the abstract entitled “Preliminary Results of a Phase I/II-Study in Pancreatic Carcinoma, Malignant Melanoma, and Colorectal Carcinoma with the TGF-beta2 Inhibitor AP 12009” has been selected for poster presentation at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO), which will be held in Chicago, Illinois, U.S.A, from June 1st - 5th.

In the Phase I/II-trial the antisense drug AP 12009 is administered intravenously in patients with either pancreatic carcinoma (stage IVA/IVB), metastatic melanoma (stage III/IV), or advanced colorectal carcinoma (stage III/IV) as a 7-day continuous infusion every other week. “The first milestone of the study has been achieved, as the maximum tolerated dose was determined with this treatment schedule”, explains Hubert Heinrichs, M.D., Ph.D., Chief Medical Officer at Antisense Pharma. Patient recruitment is still ongoing in study sites in Germany as further dose escalations with a modified dosing schedule are now performed. The design of the study, first efficacy and safety data will be presented at the poster presentation (Poster Board No. AA5, Abstract ID 4607) on June 4th 2007 from 8:00 a.m. to 12:00 p.m. in the session “Gastrointestinal (Noncolorectal) Cancer”. Prof. Thomas Seufferlein, Vice Head of the Department of Internal Medicine at the University of Ulm and Principal Investigator of the Phase I/II-Study will be available for questions from 11:00 a.m. to 12:00 p.m. at the poster in Hall A2 on Level 3 of McCormick Place South Building.

About Antisense Pharma

Antisense Pharma is a biopharmaceutical company located in Regensburg, Germany. The company focuses on targeted therapies for malignant tumors and is dedicated to discovering and developing drugs based on antisense technology for worldwide commercialization.


'"/>




Page: 1 2

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Phase data Systemic Application the TGF beta2 inhibitor Presented
(Date:4/28/2015)... Ore. , April 28, 2015 Semler ... risk assessment company that develops, manufactures and markets patented ... evaluating chronic diseases, today announced that it has received ... insurance plans in the country who offer Medicare Advantage ... the top 15 insurance plans who are now customers ...
(Date:4/28/2015)... -- Recent Highlights: , Cleared ... PerClot ® IDE CryoLife, Inc. (NYSE: ... processing company focused on cardiac and vascular surgery, announced ... Pat Mackin, Chairman, President and Chief ... two of our top organizational objectives.  First, following a ...
(Date:4/28/2015)... , April 28, 2015   HX360 ... the winners of the inaugural HX360 Innovation ... companies demonstrating improved patient experience in hospital and ... from an original field of eighty-three entries, with ... a judging panel during the HX360 Innovation Challenge ...
Breaking Medicine Technology:Semler Adds Top Insurance Plan to Customer List 2Semler Adds Top Insurance Plan to Customer List 3CryoLife Reports First Quarter Results 2CryoLife Reports First Quarter Results 3CryoLife Reports First Quarter Results 4CryoLife Reports First Quarter Results 5CryoLife Reports First Quarter Results 6CryoLife Reports First Quarter Results 7CryoLife Reports First Quarter Results 8CryoLife Reports First Quarter Results 9Ginger.io And WiserCare Named Winners Of The HX360 Innovation Challenge 2Ginger.io And WiserCare Named Winners Of The HX360 Innovation Challenge 3
... study shows 90-day statin drug claims filled through a mail ... supply from a retail pharmacy. The findings of the study ... management, will be presented at the Academy of Managed Care ... Minn. April 27-29. Waste occurs when patients stop ...
... /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: ... diagnostic ("IVD") company, today announced that it will report ... ("4Q FY2010") and the full fiscal year ended March ... June 2, 2011. The Company will also ...
Cached Medicine Technology:For Patients on Statins, Study Finds Filling 90 Day Supply Prescriptions through Mail Service Compared to Retail Pharmacy is Associated with Less Waste 2China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2011 on June 2, 2011 2
(Date:4/28/2015)... (PRWEB) April 28, 2015 Jovium®, a ... to achieve a better emotional balance, has begun to ... on an international scale to enhance their mood and ... depression. , The Jovium® System aims to help patients ... mental health conditions through all-natural products that do not ...
(Date:4/28/2015)... Omaha, NE (PRWEB) April 28, 2015 ... federal district are among the top areas that healthcare ... Medical Group, aureusmedical.com, during the month of March 2015. ... which specializes in travel nurse jobs , ... hire positions within nursing and allied health fields. ...
(Date:4/28/2015)... Aliso Viejo, CA (PRWEB) April 28, 2015 ... created for use in Final Cut Pro X ... attention to specific areas on-screen with classic buttons, animated ... Annotate is the perfect compliment to vlogs, video series, ... Cut Pro X 10.2 or newer. ProTube Annotate ...
(Date:4/28/2015)... MD (PRWEB) April 28, 2015 ... podiatrist Dr. Stephen D. Palmer ( Annapolis ... outstanding service to podiatry at the Maryland Podiatric Medical ... graduated from Kansas State University in 1992 with a ... State, Dr. Palmer participated in intercollegiate soccer, track and ...
(Date:4/28/2015)... 2015 Foundations Recovery Network (FRN), an ... the rebranding of its Memphis based residential treatment facility. ... will now be known as The Oaks at LaPaloma, ... stand of beautiful old Oak trees long regarded for ... be new, the commitment and dedication to helping people ...
Breaking Medicine News(10 mins):Health News:Jovium® Products Help Customers to Achieve Emotional Balance 2Health News:Hot States for Medical Careers: Healthcare Staffing Agency Aureus Medical Releases Online Search Results 2Health News:FCPX plugin developer Pixel Film Studios releases Protube Annotate plugin for Final Cut Pro X. 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Podiatrist Receives Maryland Podiatric Medical Association Outstanding Service Award 2Health News:Foundations Recovery Network Rebrands LaPaloma Treatment Center as The Oaks at LaPaloma 2
... 6 To help raise awareness about the,prevalence ... injured,while serving our country, TriWest Healthcare Alliance has ... for TBI. "According to the Department of ... service members sustaining injuries in the Global War,on ...
... What: HCA,s 3rd Quarter 2007 Conference ... a.m. Eastern, Where: http://www.videonewswire.com/event.asp?id=42119 , ... Simply log on to the web at the ... If you are unable to participate during the live webcast, the ...
... The American Public,Health Association today adopted 20 ... from food safety and obesity to personal hygiene ... of some of the various measures approved,by the ... in,Washington, D.C., Nov. 3-7. Full policies will be ...
... to cardiovascular disease and cancer, research finds, , , TUESDAY, Nov. 6 ... carrying excess weight, a pair of new studies has good news ... little extra weight may not shorten your life but may make ... , The studies, which are published in the Nov. 7 issue ...
... - COMPLAINT AND ATTORNEY INTERVIEWS AVAILABLE -, LONG ... #07CC01402), was filed today in Orange County Superior Court,against ... Management, Inc.; and its 15 skilled nursing care facilities,around ... release] on behalf of Donald,Boone by and through his ...
... Watchers,International, Inc. (NYSE: WTW ) today announced results for ... Results For the third quarter of 2007, net revenues ... million in the third quarter of,2006. Fully diluted earnings per ... $0.62 versus $0.52 in the prior year period. Net ...
Cached Medicine News:Health News:TriWest Contributes $50,000 to Bob Woodruff Family Fund for Traumatic Brain Injury 2Health News:APHA Adopts New Policies on Food Safety, Global Climate Change, Multidrug-Resistant Organisms, Breastfeeding and Feminine Hygiene 2Health News:APHA Adopts New Policies on Food Safety, Global Climate Change, Multidrug-Resistant Organisms, Breastfeeding and Feminine Hygiene 3Health News:APHA Adopts New Policies on Food Safety, Global Climate Change, Multidrug-Resistant Organisms, Breastfeeding and Feminine Hygiene 4Health News:Obesity Leaves More Americans With Physical Limitations 2Health News:Obesity Leaves More Americans With Physical Limitations 3Health News:Obesity Leaves More Americans With Physical Limitations 4Health News:Class Action Lawsuit Filed Against 15 California Nursing Homes 2Health News:Class Action Lawsuit Filed Against 15 California Nursing Homes 3Health News:Weight Watchers Announces Third Quarter 2007 Results 2Health News:Weight Watchers Announces Third Quarter 2007 Results 3Health News:Weight Watchers Announces Third Quarter 2007 Results 4Health News:Weight Watchers Announces Third Quarter 2007 Results 5Health News:Weight Watchers Announces Third Quarter 2007 Results 6Health News:Weight Watchers Announces Third Quarter 2007 Results 7
... comes at a very attractive price. ,The following adjustments can ... 4 1/8" to 5 1/2" (98 to 135mm), Nose ... PD adjustable 24 to 40mm on each side (48mm to ... left - 120 to 0 to 135 , right - ...
... blades offer the superior cutting advantages ... plus the exclusive Rib-Back design for ... brand producer offer the wide selection ... scalpels. Every blade is packaged in ...
BD Beaver Chondroplastic blade, sharp on two sides, curved, sterile...
RM-1970 Mucotome ergonomic design with E-Type coupling, designed for mucosal repair surgery....
Medicine Products: